PAAB Advisory - May 2000 - 2000-05-01 Code Section 7.8 Update & Fair Balance in Drug Advertising

PAAB Code Revision

At the PAAB General Meeting of April 29, 2000, the PAAB members agreed to revise PAAB Code of Advertising Acceptance section 7.8 and Explanatory Note section 7.8.1. This revision will help clarify to advertisers that pre-Notice of Compliance advertising is not acceptable within the PAAB Code. Messages paid by pharmaceutical companies to provide information about therapeutic classes of drugs or treatment of disease require PAAB preclearance review. Some messages may not be deemed to be “advertising” by the Health Canada definition but are deemed to be advertising by the PAAB Code definition. This includes “teaser ads” that may not comply with the PAAB Code. Therefore, it necessitates the need for PAAB review of this type of advertising.

/resources/PAAB_Advisory_-_May_2000.pdf

TOPICS

PAAB Q&A

Do you have questions? We have answers!

Learn More

POPULAR TOPICS

Powered by Innovasium